Finally, exosomal L1CAM is produced by patient-derived primary GBM cells [40,41] and can be recovered from blood and ascites from ovarian cancer patients [42] and may promote as platform L1CAM cleavage or systemic delivery vehicle of membrane-bound L1CAM forms [43]. The gene discussed is L1CAM; the disease is ovarian cancer.